Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

New Drug Application News Monitoring

Get by Email • RSS

Published on 12:05 GMT

SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral ...

TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) -- – SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on 15:18 GMT

Scienture's Arbli Losartan Oral Suspension Gets FDA Approval; Stock Up In Pre-market

Scienture Holdings, Inc. (SCNX), a holding company for existing and planned pharmaceutical operating companies, announced Tuesday that the U.S. Food and Drug Administration has approved SCN-102 with the brand name Arbli (losartan potassium) Oral Suspension …

Source: RTTNews - Neutral
Published on Mar 17, 2025

FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges

On Monday, the U.S. Food and Drug Administration (FDA) lifted the clinical hold on vTv Therapeutics Inc.’s VTVT cadisegliatin clinical program. The program includes the CATT1 Phase 3 trial in type 1 diabetes (T1D). Cadisegliatin is an oral, liver- …

Source: Benzinga - Neutral
Published on 01:53 GMT

RNA Therapies Clinical Trials And Pipeline 2025: EMA, PDMA, FDA Approvals, Medication, IND, NDA Approval, Therapies, ...

(MENAFN- GetNews) "RNA Therapies Clinical Trials"RNA therapies companies are Novartis, Arrowhead Pharmaceuticals, Arbutus Biopharm, Dicerna Pharmaceuticals, Inc., SanegeneBio, Alnylam Pharmaceuticals, Eli Lilly and Company, Janssen …

Source: MENAFN - Uncategorized
Published on Mar 17, 2025

vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes CATT1 Phase 3 trial expected to resume following submission of protocol amendment shortening the overall duration of the trial from 12 to 6 months HIGH POINT, N.C., …

Distribution channels: Media, Advertising & PR, Technology ...
Published on 14:33 GMT

DeFloria Achieves Ground-Breaking Milestone in Botanical Drug Development

Last month, DeFloria Inc.—a joint venture between Ajna BioSciences PBC and Charlotte’s Web Holdings Inc.—announced a milestone in its development of an oral multi-cannabinoid drug for the treatment of symptoms of autism spectrum disorder (ASD). In a first …

Source: Cannabis Business Times - Neutral
Published on 19:43 GMT

MG Infusions - 696890 - 03/10/2025

Delivery Method: VIA Electronic Mail Reference #: CBER 25-696890 Product: Biologics Recipient: Recipient Name Michael Garcia MG Infusions United States mginfusions@gmail.com Issuing Office: Center for Biologics Evaluation and Research (CBER) United States …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on 11:22 GMT

Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt ...

Four new funding proposals, totalling US$117.5 million, have been submitted for review Modifications received to U.S. Air Force Academy Cooperative Agreement Outside date for going-private transaction extended to March 31, 2025 HALIFAX, Nova Scotia, March …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on 13:30 GMT

Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) ...

First US Phase 3 study of Photodynamic Therapy (PDT) to include neck, trunk and extremities Protocol involves one or two PDT treatments using 1-3 tubes of Ameluz® or vehicle gel over a surface area of up to 240 cm2 Treatment phase expected to be complete …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on 11:50 GMT

China NMPA approves Akeso's penpulimab for first-line treatment of nasopharyngeal cancer

Akeso Inc., a biopharmaceutical company, announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for the first-line treatment of recurrent …

Source: Pharmabiz.com - Neutral
Published on 13:06 GMT

OPKO and Entera Link Up to Advance First Oral GLP-1/Glucagon Drug Into Clinic

OPKO Health and Entera Bio on Monday teamed up to push an investigational oral obesity drug into clinical trials. The partners expect to file an Investigational New Drug application “later this year,” according to a statement. If and when the partners do …

Source: BioSpace - Label Pending
Published on 17:25 GMT

FDA Approves SCN-102, Liquid Oral Suspension Formulation of Losartan

The FDA approved SCN-102 (Arbli; Sceinture LLC), the 10-mg/mL oral suspension formulation of losartan potassium (Cozaar; Organon & Co.), for the treatment of adult and pediatric patients aged 6 years and older with hypertension, for the reduction …

Source: Pharmacy Times - Neutral
Published on 16:54 GMT

Shilpa Biologicals and mAbTree Biologics to Collaborate on Novel Immuno-Oncology Asset

Editor's note: this story was originally published on BioPharm International.com. India-based Shilpa Biologicals, a fully owned subsidiary of Shilpa Medicare Limited, announced on March 17, 2025 that it has entered into a strategic partnership with …

Source: Pharmaceutical Technology - Neutral
Published on 11:50 GMT

Opko Health, Entera Bio ink collaboration agreement to advance oral GLP-1/glucagon tablet candidate into the clinic to ...

Opko Health, Inc., a multinational biopharmaceutical and diagnostics company, and Entera Bio Ltd., a leader in the development of oral peptides and proteins replacement therapies, entered into a collaboration and license agreement to advance into the …

Source: Pharmabiz.com - Neutral
Published on 16:15 GMT

What's Going On With Scienture Shares Tuesday?

Scienture Holdings, Inc. SCNX shares initially traded higher on Tuesday but have since reversed after the Food and Drug Administration (FDA) approved its new drug application for Arbli. What To Know: Arbli (losartan potassium) is first and only FDA …

Source: Benzinga - Neutral
Published on 19:11 GMT

Opko and Entera focus on oral care for obesity and metabolic disorders

Opko Health and Entera Bio have announced a partnership and licence agreement to progress the development of the first oral dual agonist glucagon-like peptide-1 (GLP-1)/glucagon, aiming to provide treatment for individuals with metabolic, fibrotic and …

Source: Pharmaceutical Technology - Neutral
Published on 16:50 GMT

Penpulimab Gains NMPA Approval for First-Line Treatment of Recurrent or Metastatic NPC

Penpulimab (formerly AK105), an anti–PD-1 monoclonal antibody, has received approval from the National Medical Products Administration (NMPA) for use in combination with chemotherapy as a first-line treatment for patients with recurrent or metastatic …

Source: OncLive - Label Pending
Published on 02:15 GMT

Avutometinib/Defactinib Combo Drives Responses in Recurrent Low-Grade Serous Ovarian Cancer

Treatment with the combination of avutometinib (VS-6766) and defactinib (VS-6063) led to a clinically meaningful overall response rate (ORR), duration of response (DOR), and progression-free survival (PFS) in patients with recurrent low-grade serous …

Source: OncLive - Label Pending
Published on 01:25 GMT

Kidney Disease Treatment sNDA Submitted to FDA for Approval

Travere Therapeutics, Inc. announced the company has submitted a supplemental New Drug Application (sNDA) to the FDA seeking priority review for traditional approval of FILSPARI® (sparsentan) for the treatment of focal segmental glomerulosclerosis (FSGS). …

Source: American Pharmaceutical Review - Neutral

days

hours

minutes

seconds

Featured Releases

Got News to Share? · Submit · See All

Published on March 18, 2025 - 11:00 GMT

HMP Global’s Drug Channels Institute releases ‘2025 Economic Report on U.S. Pharmacies and PBMs,’ examining $683B market

New report analyzes market trends, consolidation, and the evolving role of Pharmacy Benefit Managers in the U.S. drug industry. MIAMI, FL, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- Drug Channels Institute (DCI), an HMP Global Company, …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 18, 2025 - 11:52 GMT

Alopecia Drugs Market to Grow at 9.95% CAGR, Surpassing USD 23.34 Billion by 2032

Alopecia Drugs Market Size was valued at USD 10.84 Billion in 2023. The Global Alopecia Drugs industry is projected to grow from USD 11.8 Billion in 2024 NY, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- The global alopecia drugs market is …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on March 18, 2025 - 12:21 GMT

Erythropoietin Drugs Market Poised for Massive Growth, Projected to Hit $24.6 Billion by 2032 at 9.68% CAGR

The main factor compelling the expansion of the erythropoietin market is the rise in anemic conditions caused by chemotherapy, antiretroviral treatment (ART) US, NY, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- In the evolving landscape …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 15:52 GMT

Antimicrobial Resistance Market to Reach $9.5 Bn, Globally, by 2032 at 7.6% CAGR | Innoviva, Inc, Pfizer, Merck & Co

PORTLAND, IA, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- The global antimicrobial resistance market was valued at $4.6 billion in 2022, and is projected to reach $9.5 billion by 2032, registering a CAGR of 7.6% from 2023 to 2032. …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on March 18, 2025 - 14:32 GMT

Radiopharmaceuticals Market to Reach $21.8 bn, Globally, by 2033 at 10.6% CAGR | GE Healthcare, Novartis AG, Bayer AG

PORTLAND, IA, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- According to the report, the radiopharmaceuticals market was valued at $7.9 billion in 2023 and is estimated to reach $21.8 billion by 2033, growing at a CAGR of 10.6% from 2024 to …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 11:24 GMT

Global Home Medical Equipment Market Set to Witness Significant Growth by 2025-2032: AstraZeneca, Baxter, GE Healthcare

BURLINGAME, CA, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- The Global Home Medical Equipment Market is expected to grow at 6.78% CAGR from 2025 to 2032. The latest Research report published by Coherent Market Insights with the title …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 10:25 GMT

U.S. Contraceptives Drugs And Devices Market Set to Witness Significant Growth by 2025-2032: Merck & Co. Inc, Bayer AG

BURLINGAME, CA, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- The Global U.S. Contraceptives Drugs And Devices Market is expected to grow at 5.6% CAGR from 2025 to 2032. The latest Research report published by Coherent Market Insights …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 11:40 GMT

Pharmaceutical Robots Market Detailed In New Research Report 2025 | ABB Ltd, Seiko Epson Co, Universal Robots A/S

BURLINGAME, CA, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- The Global Pharmaceutical Robots Market is expected to grow at 8.9% CAGR from 2025 to 2032. The latest Research report published by Coherent Market Insights with the title …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 795,016,697 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 02/17/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on March 18, 2025 - 20:10 GMT

AMIGOS INTERNACIONALES AND DOCTORS ON MISSION HOSTS MAJOR 3-DAY MEDICAL CAMP WITH SUPPORT FROM UGANDAN HEART INSTITUTE

Amigos Internacionales and Doctors on Mission will host a 3-day medical camp in Ogul, Uganda (March 28–31) with heart care from the Ugandan Heart Institute. OGUL VILLAGE, UGANDA, March 18, 2025 /⁨EINPresswire.com⁩/ -- Kampala, Uganda – March 18, …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 19:43 GMT

X-ray Revolution: Insights into Market Dynamics and Innovations | $24.9 billion by 2032

The global X-ray market size was valued at $13.4 billion in 2022 and is projected to reach $24.9 billion by 2032, growing at a CAGR of 6.4% from 2023 to 2032. PORTLAND, OR, UNITED STATES, March 19, 2025 /⁨EINPresswire.com⁩/ -- X-ray imaging refers …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on March 18, 2025 - 19:41 GMT

Increased Awareness of Male Pattern Baldness Drives Demand in Finasteride Market | $546.7 Million by 2031

The global finasteride market size is projected to reach $546.7 million by 2031, growing at a CAGR of 4.2% from 2022 to 2031. PORTLAND, OR, UNITED STATES, March 19, 2025 /⁨EINPresswire.com⁩/ -- The finasteride market has experienced significant …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 19:39 GMT

Seattle’s Dr. Shea Kramer Brings Life-Changing Family, Pediatric, and Prenatal Chiropractic Care to Her Community

SEATTLE, WA, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- As more families seek natural and holistic approaches to healthcare, pediatric and prenatal chiropractic care is gaining recognition as a safe and viable option for promoting …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 19:22 GMT

Global Olanzapine Market to Reach $2.2 Billion by 2031 | CAGR 2.3%

The global olanzapine market size is projected to reach $2.2 billion by 2031, growing at a CAGR of 2.3% from 2022 to 2031. PORTLAND, OR, UNITED STATES, March 19, 2025 /⁨EINPresswire.com⁩/ -- Olanzapine is a medication that is primarily used to …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 19:17 GMT

Social Story Creator Empowers Educators, Therapists and Caregivers with Personalized Tool for Autistic Learners

AI-powered Social Story Creator helps parents, educators, and therapists instantly create personalized social stories, empowering autistic learners. TORONTO, ONTARIO, CANADA, March 18, 2025 /⁨EINPresswire.com⁩/ -- Parents, educators, therapists, …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on March 18, 2025 - 19:16 GMT

DiabetesSisters Unveils AI-Driven Strategies at ATTD 2025 to Empower Underserved Women

Organization Leverages Predictive Analytics and an Evidence-Based Peer Support Model to Expand Reach, Strengthen Engagement, and Improve Health Literacy RALEIGH, NC, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- DiabetesSisters, a national …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 19:12 GMT

MAPS Launches Groundbreaking Foundations in Medical Affairs Certificate Program to Empower Professionals Worldwide

MAPS is enhancing the Medical Affairs field with its new Foundations in Medical Affairs Certificate Program, helping professionals improve standards worldwide. GOLDEN, CO, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- The Medical Affairs …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
Published on March 18, 2025 - 19:09 GMT

Elate Orthodontics Expands Access to High-Quality Orthodontic Care Along FM 423 in Frisco, The Colony, and Prosper

With multiple locations along FM 423, Elate Orthodontics ensures families in North Texas have access to advanced, affordable orthodontic care close to home. FRISCO, TX, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- Families living along FM …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 19:07 GMT

Bio Sensing Technologies Introduces the Smart HEAD System™: Real-Time Head Biometric Tracking for Athlete Safety

Bio Sensing Technologies, a pioneer in sports safety and wearable technology, is proud to unveil the Smart HEAD System™ COLORADO SPRINGS, CO, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- The Smart HEAD System™ is an advanced device …

Distribution channels: Healthcare & Pharmaceuticals Industry, Military Industry ...
Published on March 18, 2025 - 19:00 GMT

NAFC Awards Sandip Vasavada, MD SUFU 2025 Continence Care Champion

The National Association for Continence named Dr. Sandip Vasavada as the 2025 recipient of the Rodney Appell Continence Care Champion Award. PALM SPRINGS, CA, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- NAFC Awards Sandip Vasavada, MD …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 18:51 GMT

PromiCell Launches Investment Campaign to Advance Breakthrough Cell Therapy for Cancer

PromiCell, a clinical-stage immunotherapy company, launches an accredited investor-only campaign to advance next-gen CAR T & TCR T cancer treatments. MIAMI, FL, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- PromiCell Launches …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 18:30 GMT

MCON and PsychArmor Announce Strategic Partnership to Improve Healthcare Outcomes for the Military Community

The first-of-its-kind program will drive innovation supporting active duty service members, veterans, and their families. LAS VEGAS, NV, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- MCON HEALTH and PsychArmor, a leader in military …

Distribution channels: Aviation & Aerospace Industry, Conferences & Trade Fairs ...
Published on March 18, 2025 - 17:49 GMT

BENCO DENTAL PARTNERS WITH CHALICE MD and PAYCHEX PEO to OFFER GROUP HEALTH INSURANCE BENEFITS TO DENTAL PROFFESSIONALS

BENCO to OFFER AFFORDABLE GROUP HEALTH INSURANCE THROUGH PARTNERSHIP WITH CHALICE MD and Paychex PEO MELBOURNE, FL, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- Benco Dental, the nation’s largest independent distributor of oral healthcare …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 18, 2025 - 17:25 GMT

THE EAGLEMANIACS TO HEADLINE THE FIRST HORIZON BANK ENCORE ENTERTAINMENT AT THE ST. JUDE ROCK ‘N’ ROLL NASHVILLE

THE 25TH RUNNING OF THE RACE TAKES PLACE ON SATURDAY, APRIL 26, 2025 NASHVILLE, TN, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- Celebrating 25 Years Running, the St. Jude Rock ‘n’ Roll® Running Series Nashville announced today that …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 18, 2025 - 17:21 GMT

Sandstone Chiropractic Launches New Website to Enhance Patient Experience

A Modern, User-Friendly Platform Designed to Improve Access to Chiropractic Care and Wellness Resources for North Houston THE WOODLANDS, TX, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- Sandstone Chiropractic, under the leadership of Dr. …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on March 18, 2025 - 17:03 GMT

A Defining Moment for Global Health: WHO Releases Groundbreaking Patient Blood Management Implementation Guidance

WHO’s new PBM guidance helps optimize blood use, improve patient outcomes, and reduce healthcare costs while addressing risks associated with blood transfusion. LONDON, UNITED KINGDOM, March 19, 2025 /⁨EINPresswire.com⁩/ -- The global medical …

Distribution channels: Book Publishing Industry, Education ...
Published on March 18, 2025 - 16:44 GMT

Carr Legal Group Welcomes New Associate Attorney Joseph T. Siegel

New associate attorney Joseph T. Siegel joins Carr Legal Group, bringing a passion for personal injury law and dedication to representing the underdog. BEAUFORT, SC, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- Carr Legal Group has …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on March 18, 2025 - 16:37 GMT

ONE-MAN SHOW CONFIDENCE MATTERS! STARRING DW STARR TO PREMIERE MARCH 22nd IN ORLANDO

CONFIDENCE MATTERS! is an interactive, fun, energetic, and mind expanding theatrical play written especially for youth to teach them how to be more confident. ORLANDO, FL, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- MEDIA ADVISORY …

Distribution channels: Amusement, Gaming & Casino, Culture, Society & Lifestyle ...
Published on March 18, 2025 - 16:06 GMT

IgA Nephropathy Foundation Celebrates 20 Years of Advocacy, Research, and Patient Support

IgA Nephropathy Foundation celebrates 20 years of advocacy, research, and patient support, advancing care and pushing for a cure. WALL TOWNSHIP, NJ, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- The IgA Nephropathy (IgAN) Foundation marks …

Distribution channels: Conferences & Trade Fairs, Education ...

Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Join thousands of professionals. Stay current. Stay competitive.

Track news from thousands of sources
Submit news sources for inclusion in our news tracking algorithm
Build your own customized email newsletters

Use of our RSS Feeds
Includes a complimentary EIN Presswire account plus 1-free release
Uncluttered & advertising free news pages